Literature DB >> 3262925

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

S Nakamura1, S Z Salahuddin, P Biberfeld, B Ensoli, P D Markham, F Wong-Staal, R C Gallo.   

Abstract

Studies of the biology and pathogenesis of Kaposi's sarcoma (KS) have been hampered by the inability to maintain long-term cultures of KS cells in vitro. In this study AIDS-KS-derived cells with characteristic spindle-like morphology were cultured with a growth factor (or factors) released by CD4+ T lymphocytes infected with human T-lymphotropic virus type I or II (HTLV-I or HTLV-II) or with human immunodeficiency virus type 1 or 2 (HIV-1 or HIV-2). Medium conditioned by HTLV-II-infected, transformed lines of T cells (HTLV-II CM) contained large amounts of this growth activity and also supported the temporary growth of normal vascular endothelial cells, but not fibroblasts. Interleukin-1 and tumor necrosis factor-alpha stimulated the growth of the KS-derived cells, but the growth was only transient and these could be distinguished from that in HTLV-II CM. Other known endothelial cell growth promoting factors, such as acidic and basic fibroblast growth factors and epidermal growth factor, did not support the long-term growth of the AIDS-KS cells. The factor released by CD4+ T cells infected with human retroviruses should prove useful in studies of the pathogenesis of KS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262925     DOI: 10.1126/science.3262925

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  64 in total

1.  Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  HIV-1 promotor insertion revealed by selective detection of chimeric provirus-host gene transcripts.

Authors:  I Raineri; H P Senn
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

4.  Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV.

Authors:  Tiffany Jones; Fengchun Ye; Roble Bedolla; Yufei Huang; Jia Meng; Liwu Qian; Hongyi Pan; Fuchun Zhou; Rosalie Moody; Brent Wagner; Mazen Arar; Shou-Jiang Gao
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

5.  Ultrastructural development of Kaposi's sarcoma in relation to the dermal microvasculature.

Authors:  M Dictor; B Carlén; N Bendsöe; L Flamholc
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  HIV-associated Kaposi's sarcoma: new developments in epidemiology and molecular pathology.

Authors:  W K Roth
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  A temporal study of the lesions induced by MoMuSV-349.

Authors:  R J Hoffman; G Stoica
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

8.  Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.

Authors:  J Cai; P S Gill; R Masood; P Chandrasoma; B Jung; R E Law; S F Radka
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.

Authors:  J Corbeil; E Rapaport; D D Richman; D J Looney
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 10.  Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.

Authors:  H Albrecht; E B Helm; A Plettenberg; C Emminger; W Heise; B Schwartländer; H J Stellbrink
Journal:  Genitourin Med       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.